Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ľudovít Gašpar"'
Autor:
Ľudovít GAŠPAR, Iveta GAŠPAROVÁ
Publikováno v:
Pedagogical Sections. Conference Proceedings.
Autor:
Na A Bežillová, Iveta Gasparova, Peter Gavorník, Dáša Mesárošová, Ľudovít Gašpar, Gabriela Gubo, Eva Gavorníková, Martina Kováčová, Andrej Dukát, Alena Uhrinová, Katarína Kusendová, Marek Kucera, Matej Bendžala, Lujza Sabolová, Anna Petrášová
Publikováno v:
Vnitřní lékařství. 65:326-334
Koncatinovocievna arteriova ischemicka choroba (periferne arteriove ochorenie dolných koncatin - PAO DK) je doležitou manifestaciou systemovej aterosklerozy a iných arteriových chorob cievneho systemu. Cim nižsi je clenkovo-ramenový tlakový in
Autor:
Iveta Gasparova, Ľudovít Gašpar
Publikováno v:
12th International Conference of J. Selye University. Economics Section. Conference Proceedings.
Autor:
Juraj Štofko, Ľudovít Gašpar
Publikováno v:
11th International Conference of J. Selye University. Pedagoogical Sections. Conference Proceedings.
[Antiplatelet thromboprophylaxis of arterial vascular diseases and organovascular ischemic diseases]
Autor:
Anna Petrášová, Eva Gavorníková, Andrej Dukát, Lujza Sabolová, Naďa Hučková, Gabriela Gubo, Ľudovít Gašpar, Iveta Gasparova, Peter Gavorník
Publikováno v:
Vnitrni lekarstvi. 63(2)
Antiplatelet therapy by acetylsalicylic acid (ASA, aspirin) provided pivotal advances in the prevention and treatment of organovascular (angiovascular, cardiovascular, cerebrovascular, extremitovascular, renovascular, genitovascular, mesenteriointest
Publikováno v:
International Angiology. 36
BACKGROUNDː The aim of the study was to evaluate the clinical significance of baroreflex sensitivity (BRS) and carotid intima media thickness (IMT) in risk stratification of hypertensives and subjects with high normal blood pressure (SHNBP). METHODS
Publikováno v:
Vnitrni lekarstvi. 62(9)
Until recently, vitamin K antagonists (VKA; predominantly warfarin) were the only oral anticoagulants for primary and secondary prevention of venous thromboembolism. Prevention and therapy with novel, direct, non-VKA oral anticoagulant agents (NOACs;
Autor:
Andrej, Dukát, Peter, Sabaka, Ján, Gajdošík, Marjan, Vrbnjak, Oliver, Tlčimuka, Peter, Gavorník, Ľudovít, Gašpar, F, Šimko
Publikováno v:
Vnitrni lekarstvi. 61(12 Suppl 5)
Hyperuricaemia represents nowaday the new risk factor for cardiovascular diseases. Prevalence data and its treatment in our patient´s population are still missing. Literature data shows, that its prevalence differs in various populations significant
Autor:
Peter, Gavorník, Andrej, Dukát, Ľudovít, Gašpar, Naďa, Hučková, Laura, Slezáková, Katarína, Kusendová, Gabriela, Gubo, Denisa, Medová, Xénia, Faktorová, Eva, Gavorníková
Publikováno v:
Vnitrni lekarstvi. 61
The aim of this review is to address documents and a number of studies on hypertension published in the last years in order to assess their contribution to our expanding knowledge of arterial hypertension.Arterial hypertension is not defined by sympt
Publikováno v:
Cor et Vasa. 49:55-60